$139 Million is the total value of Newman Dignan & Sheerar, Inc.'s 145 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LIQDQ | Exit | Liquid Hldgs Group Inc | $0 | – | -10,000 | -100.0% | -0.00% | – |
TEAR | Exit | Tearlab Corp | $0 | – | -10,000 | -100.0% | -0.01% | – |
RENN | Exit | Renren Inc Adradr | $0 | – | -20,150 | -100.0% | -0.04% | – |
WMT | Exit | Wal-Mart Stores | $0 | – | -2,436 | -100.0% | -0.14% | – |
EPD | Exit | Enterprise Prd Prtnrs Lp | $0 | – | -6,125 | -100.0% | -0.14% | – |
NOV | Exit | National Oilwell Varco, Inc. | $0 | – | -4,156 | -100.0% | -0.15% | – |
PCL | Exit | Plum Creek Timber | $0 | – | -4,881 | -100.0% | -0.15% | – |
RDSA | Exit | Royal Dutch Shell PLC | $0 | – | -3,551 | -100.0% | -0.15% | – |
VPU | Exit | Vanguard Utilitiesetf | $0 | – | -2,225 | -100.0% | -0.15% | – |
Exit | Air Prods & Chems | $0 | – | -1,800 | -100.0% | -0.19% | – | |
Exit | Target Corp | $0 | – | -3,580 | -100.0% | -0.21% | – | |
HSBCPRA | Exit | H S B C Hldgs 6.2% Pfdpfd | $0 | – | -20,500 | -100.0% | -0.38% | – |
GOV | Exit | Government Property Income Truetf | $0 | – | -24,770 | -100.0% | -0.40% | – |
LOW | Exit | Lowes Companies | $0 | – | -7,612 | -100.0% | -0.40% | – |
Exit | Molson Coors Brewing | $0 | – | -11,500 | -100.0% | -0.61% | – | |
MDT | Exit | Medtronic plc | $0 | – | -21,061 | -100.0% | -1.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-07-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Schwab Dow Jones US Div Eq ETF | 42 | Q3 2023 | 6.6% |
Schwab Dow Jones US Large Cap ETF | 42 | Q3 2023 | 7.3% |
Schwab Dow Jones US Large Growth ETF | 42 | Q3 2023 | 4.9% |
Schwab Dow Jones US Large Value ETF | 42 | Q3 2023 | 4.5% |
Apple, Inc | 42 | Q3 2023 | 20.8% |
Schwab Dow Jones US Sm-Cap ETF | 42 | Q3 2023 | 13.5% |
Microsoft Corp | 42 | Q3 2023 | 3.4% |
Johnson & Johnson | 42 | Q3 2023 | 2.9% |
Novartis A G | 42 | Q3 2023 | 56.8% |
Merck & Co Inc | 42 | Q3 2023 | 2.5% |
View Newman Dignan & Sheerar, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-29 |
13F-HR | 2024-02-09 |
13F-HR | 2023-11-08 |
13F-HR | 2023-08-02 |
13F-HR | 2023-04-28 |
13F-HR | 2023-01-20 |
13F-HR | 2022-10-18 |
13F-HR | 2022-08-03 |
13F-HR | 2022-04-14 |
13F-HR | 2022-01-18 |
View Newman Dignan & Sheerar, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.